Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Abdhish Bhavsar, MD
Retina Center, PA
Study Chair - Adam R. Glassman, MS
Jaeb Center for Health Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
67 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Retinal Consultants of Az
Phoenix, Arizona, United States
- University of California, Irvine
Irvine, California, United States
- Loma Linda University Health Care, Dept. of Ophthalmology
Loma Linda, California, United States
- Southern California Desert Retina Consultants, Mc
Palm Springs, California, United States
- Bay Area Retina Associates
Walnut Creek, California, United States
- Retinal Consultants of Southern California Medical Group, Inc.
Westlake Village, California, United States
- Denver Health Medical Center
Denver, Colorado, United States
- New England Retina Associates, Pc
Trumbull, Connecticut, United States
- the George Washington University, Department of Ophthalmology
Washington D.C., District of Columbia, United States
- Retina Consultants of Southwest Florida
Fort Myers, Florida, United States
- University of Florida College of Med., Department of Ophthalmology
Jacksonville, Florida, United States
- Florida Retina Consultants
Lakeland, Florida, United States
- Magruder Eye Institute
Orlando, Florida, United States
- Sarasota Retina Institute
Sarasota, Florida, United States
- Retina Associates of Sarasota
Venice, Florida, United States
- Emory Eye Center
Atlanta, Georgia, United States
- Georgia Retina, P.C.
Atlanta, Georgia, United States
- Southeast Retina Center, P.C.
Augusta, Georgia, United States
- Retina Associates of Hawaii, Inc.
Honolulu, Hawaii, United States
- University of Illinois at Chicago Medical Center
Chicago, Illinois, United States
- Raj K. Maturi, M.D., P.C.
Indianapolis, Indiana, United States
- American Eye Institute
New Albany, Indiana, United States
- Medical Associates Clinic, P.C.
Dubuque, Iowa, United States
- Wolfe Eye Clinic
West Des Moines, Iowa, United States
- Sabates Eye Centers Research Division
Leawood, Kansas, United States
- Retina and Vitreous Associates of Kentucky
Lexington, Kentucky, United States
- Paducah Retinal Center
Paducah, Kentucky, United States
- Elman Retina Group, P.A.
Baltimore, Maryland, United States
- Wilmer Eye Institute at Johns Hopkins
Baltimore, Maryland, United States
- Wilmer Eye Institute at Johns Hopkins
Baltimore, Maryland, United States
- Retina Consultants of Delmarva, P.A.
Salisbury, Maryland, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
Detroit, Michigan, United States
- Vitreo-Retinal Associates
Grand Rapids, Michigan, United States
- Retina Center, Pa
Minneapolis, Minnesota, United States
- Barnes Retina Institute
St Louis, Missouri, United States
- Delaware Valley Retina Associates
Lawrenceville, New Jersey, United States
- Mount Sinai School of Medicine, Dept. of Ophthalmology
New York, New York, United States
- the New York Eye and Ear Infirmary/faculty Eye Practice
New York, New York, United States
- Retina Consultants of Western New York
Orchard Park, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 29 Feb 2012
- Completion
- 31 Jan 2013
- Last update posted
- 26 Aug 2016
- Registered enrollment
- 261
- Registry id
- NCT00996437
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.